These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28438772)

  • 1. Severe vincristine-induced polyneuropathy in a teenager with anaplastic medulloblastoma and undiagnosed Charcot-Marie-Tooth disease.
    Aghajan Y; Yoon JM; Crawford JR
    BMJ Case Rep; 2017 Apr; 2017():. PubMed ID: 28438772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low dose vincristine-induced severe polyneuropathy in a Hodgkin lymphoma patient: a case report (vincristine-induced severe polyneuropathy).
    Cil T; Altintas A; Tamam Y; Battaloğlu E; Isikdogan A
    J Pediatr Hematol Oncol; 2009 Oct; 31(10):787-9. PubMed ID: 19770686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Chauvenet AR; Shashi V; Selsky C; Morgan E; Kurtzberg J; Bell B;
    J Pediatr Hematol Oncol; 2003 Apr; 25(4):316-20. PubMed ID: 12679647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Charcot-Marie-Tooth disease type I diagnosed in a 5-year-old boy after vincristine neurotoxicity, resulting in maternal diagnosis.
    Olek MJ; Bordeaux B; Leshner RT
    J Am Osteopath Assoc; 1999 Mar; 99(3):165-7. PubMed ID: 10217912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
    Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
    Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vincristine neuropathy: neurophysiological and genetic studies in a case of Wilms tumor.
    Schiavetti A; Frascarelli M; Uccini S; Novelli A
    Pediatr Blood Cancer; 2004 Oct; 43(5):606-9. PubMed ID: 15382281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment-induced remission of medulloblastoma using a chemotherapeutic regimen devoid of vincristine in a child with Charcot-Marie-Tooth disease.
    Bernstock JD; Cohen JL; Singh S; Schlappi CW; Fiveash JB; Johnston JM; Fequiere P; Orr BA; Li R; Friedman GK
    Curr Oncol; 2019 Apr; 26(2):e266-e269. PubMed ID: 31043836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Charcot-Marie-Tooth disease and vincristine.
    Orejana-García AM; Pascual-Huerta J; Pérez-Melero A
    J Am Podiatr Med Assoc; 2003; 93(3):229-33. PubMed ID: 12756314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vincristine treatment revealing asymptomatic hereditary motor sensory neuropathy type 1A.
    Mercuri E; Poulton J; Buck J; Broadbent V; Bamford M; Jungbluth H; Manzur AY; Muntoni F
    Arch Dis Child; 1999 Nov; 81(5):442-3. PubMed ID: 10519723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy.
    Beutler AS; Kulkarni AA; Kanwar R; Klein CJ; Therneau TM; Qin R; Banck MS; Boora GK; Ruddy KJ; Wu Y; Smalley RL; Cunningham JM; Le-Lindqwister NA; Beyerlein P; Schroth GP; Windebank AJ; Züchner S; Loprinzi CL
    Ann Neurol; 2014 Nov; 76(5):727-37. PubMed ID: 25164601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vincristine exacerbates asymptomatic Charcot-Marie-tooth disease with a novel EGR2 mutation.
    Nakamura T; Hashiguchi A; Suzuki S; Uozumi K; Tokunaga S; Takashima H
    Neurogenetics; 2012 Feb; 13(1):77-82. PubMed ID: 22271166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult medulloblastoma: multiagent chemotherapy.
    Greenberg HS; Chamberlain MC; Glantz MJ; Wang S
    Neuro Oncol; 2001 Jan; 3(1):29-34. PubMed ID: 11305414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fulminant peripheral neuropathy with severe quadriparesis associated with vincristine therapy.
    Moudgil SS; Riggs JE
    Ann Pharmacother; 2000 Oct; 34(10):1136-8. PubMed ID: 11054980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life-threatening vincristine neurotoxicity.
    Naumann R; Mohm J; Reuner U; Kroschinsky F; Rautenstrauss B; Ehninger G
    Br J Haematol; 2001 Nov; 115(2):323-5. PubMed ID: 11703329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia.
    Nishikawa T; Kawakami K; Kumamoto T; Tonooka S; Abe A; Hayasaka K; Okamoto Y; Kawano Y
    J Pediatr Hematol Oncol; 2008 Jul; 30(7):519-21. PubMed ID: 18797198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vincristine treatment triggering the expression of asymptomatic Charcot-Marie-Tooth disease.
    Neumann Y; Toren A; Rechavi G; Seifried B; Shoham NG; Mandel M; Kenet G; Sharon N; Sadeh M; Navon R
    Med Pediatr Oncol; 1996 Apr; 26(4):280-3. PubMed ID: 8600343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterozygosity for CMT Type 4 Predicts a Severe Vincristine-induced Polyneuropathy Phenotype: A Case Report and Review of Literature.
    Sy A; Cheng J; Cooper R; Mueller L
    J Pediatr Hematol Oncol; 2019 Jan; 41(1):e41-e43. PubMed ID: 29877907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute neurotoxicity following vincristine due to Charcot-Marie-Tooth disease in a young child with medulloblastoma.
    Kissoon T; Gururangan S; Sladky J
    Neurooncol Pract; 2019 May; 6(3):179-184. PubMed ID: 31385990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary neuropathy with liability to pressure palsies emerging during vincristine treatment.
    Kalfakis N; Panas M; Karadima G; Floroskufi P; Kokolakis N; Vassilopoulos D
    Neurology; 2002 Nov; 59(9):1470-1. PubMed ID: 12427913
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe vincristine neuropathy in Charcot-Marie-Tooth disease type 1A.
    Graf WD; Chance PF; Lensch MW; Eng LJ; Lipe HP; Bird TD
    Cancer; 1996 Apr; 77(7):1356-62. PubMed ID: 8608515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.